Factors influencing fluoroquinolone resistance.

about

Global spread of multiple aminoglycoside resistance genes.Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties.

P2860

Q36009396-2741A496-0C2E-400F-B6C5-8D32CC489F00 Q55252138-26723726-4F53-469C-9368-6728C588DAEB

P2860

Factors influencing fluoroquinolone resistance.

Item

http://www.wikidata.org/entity/Q42590584

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Factors influencing fluoroquinolone resistance.

@en

Factors influencing fluoroquinolone resistance.

@nl

type

Item

label

Factors influencing fluoroquinolone resistance.

@en

Factors influencing fluoroquinolone resistance.

@nl

prefLabel

Factors influencing fluoroquinolone resistance.

@en

Factors influencing fluoroquinolone resistance.

@nl

P1476

Factors influencing fluoroquinolone resistance.

@en

P2093

Clyde Thornsberry

http://www.w3.org/2001/XMLSchema#string

Daniel F Sahm

http://www.w3.org/2001/XMLSchema#string

James A Karlowsky

http://www.w3.org/2001/XMLSchema#string

Mark E Jones

http://www.w3.org/2001/XMLSchema#string

P2860

A critical review of the fluoroquinolones: focus on respiratory infections

Maintaining fluoroquinolone class efficacy: review of influencing factors.

In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network.

Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms.

Pharmacodynamics and pharmacokinetics of levofloxacin.

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.

Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study

In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates.

Comparative antianaerobic activity of BMS 284756

P304

1651-1654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID0912.030168

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8918614

http://www.w3.org/2001/XMLSchema#string

P698

14725310

http://www.w3.org/2001/XMLSchema#string

P932

3034343

http://www.w3.org/2001/XMLSchema#string

Factors influencing fluoroquinolone resistance.

about

P2860

P2860

Factors influencing fluoroquinolone resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932